on QUANTEL (EPA:QUA)
Lumibird in Exclusive Talks to Sell Medical Division to IPG Photonics
On July 16, 2026, Lumibird Group announced exclusive negotiations for selling its Medical Division to IPG Photonics Corporation. The deal, valued at €300 million, could increase by €50 million based on performance in 2026 and 2027. This transaction marks a significant milestone, aiming to specialize Lumibird's divisions for future growth.
Historically, Lumibird has invested in innovation and global expansion, establishing strong market positions. The proposed sale would enable Lumibird to concentrate on its Photonics Division, enhancing financial flexibility and strategic clarity, particularly in areas such as Defence & Space and Industrial applications.
IPG Photonics is expected to offer Lumibird's Medical Division extensive industrial capabilities and market reach. The transaction aims to complete by Q4 2026, pending employee consultations and regulatory approvals. Proceeds will strengthen Lumibird's balance sheet, allowing for substantial investment in R&D and potential shareholder distributions.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all QUANTEL news